BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Serigstad S, Markussen D, Grewal HMS, Ebbesen M, Kommedal Ø, Heggelund L, van Werkhoven CH, Faurholt-Jepsen D, Clark TW, Ritz C, Ulvestad E, Bjørneklett R, Knoop ST; CAPNOR Study Group. Rapid syndromic PCR testing in patients with respiratory tract infections reduces time to results and improves microbial yield. Sci Rep 2022;12:326. [PMID: 35013351 DOI: 10.1038/s41598-021-03741-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Ferrer J, Clari MÁ, Giménez E, Carbonell N, Torres I, Blasco ML, Albert E, Navarro D. The Biofire® Filmarray® Pneumonia Plus panel for management of lower respiratory tract infection in mechanically-ventilated patients in the COVID-19 era: A diagnostic and cost-benefit evaluation. Diagnostic Microbiology and Infectious Disease 2022. [DOI: 10.1016/j.diagmicrobio.2022.115847] [Reference Citation Analysis]
2 Gómez de la Torre Pretell JC, Hueda-zavaleta M, Cáceres-delaguila JA, Barletta-carrillo C, Copaja-corzo C, Poccorpachi MDPS, Delgado MSV, Sanchez GMML, Benites-zapata VA. Clinical Characteristics Associated with Detected Respiratory Microorganism Employing Multiplex Nested PCR in Patients with Presumptive COVID-19 but Negative Molecular Results in Lima, Peru. TropicalMed 2022;7:340. [DOI: 10.3390/tropicalmed7110340] [Reference Citation Analysis]
3 Jitmuang A, Puttinad S, Hemvimol S, Pansasiri S, Horthongkham N. A multiplex pneumonia panel for diagnosis of hospital-acquired and ventilator-associated pneumonia in the era of emerging antimicrobial resistance. Front Cell Infect Microbiol 2022;12:977320. [DOI: 10.3389/fcimb.2022.977320] [Reference Citation Analysis]
4 Serigstad S, Markussen DL, Ritz C, Ebbesen MH, Knoop ST, Kommedal Ø, Heggelund L, Ulvestad E, Bjørneklett RO, Grewal HMS; CAPNOR study group. The changing spectrum of microbial aetiology of respiratory tract infections in hospitalized patients before and during the COVID-19 pandemic. BMC Infect Dis 2022;22:763. [PMID: 36180842 DOI: 10.1186/s12879-022-07732-5] [Reference Citation Analysis]
5 Gadsby NJ, Musher DM. The Microbial Etiology of Community-Acquired Pneumonia in Adults: from Classical Bacteriology to Host Transcriptional Signatures. Clin Microbiol Rev 2022;:e0001522. [PMID: 36165783 DOI: 10.1128/cmr.00015-22] [Reference Citation Analysis]
6 Serigstad S, Ritz C, Faurholt-Jepsen D, Markussen D, Ebbesen MH, Kommedal Ø, Bjørneklett RO, Heggelund L, Clark TW, van Werkhoven CH, Knoop ST, Ulvestad E, Grewal HMS; CAPNOR study group. Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR). Trials 2022;23:622. [PMID: 35915452 DOI: 10.1186/s13063-022-06467-7] [Reference Citation Analysis]
7 Andrews V, Pinholt M, Schneider UV, Schønning K, Søes LM, Lisby G. Performance of PCR-based syndromic testing compared to bacterial culture in patients with suspected pneumonia applying microscopy for quality assessment. APMIS 2022;130:417-26. [PMID: 35499302 DOI: 10.1111/apm.13232] [Reference Citation Analysis]
8 Wang Y, Liu A, Fu M, Guo J, Wang L, Zuo X, Ma F. Establishment and Clinical Application of a RPA-LFS Assay for Detection of Capsulated and Non-Capsulated Haemophilus influenzae. Front Cell Infect Microbiol 2022;12:878813. [DOI: 10.3389/fcimb.2022.878813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]